Drug discovery

AI concept
#Artificial intelligence (AI) #Contract Research Organisations (CROs) #Drug discovery

AI in drug discovery: Separating hype from reality, and what it holds for CROs

Dr Kenneth Barr, Senior Vice President, Discovery Services at Syngene International, examines the reality of using AI in drug discovery and its relevance for CROs. In an industry where investments are huge, the time to market is over a decade, and success rates hover around 10%, technological advances that significantly… Read More

#Business & Investment #Exclusive Content

Cardiovascular system
#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Webinar: How can 3D cardiac models advance drug screening?

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

#Artificial intelligence (AI) #Deep Science Ventures #Drug discovery #Fibrosis

Teaming up to tackle global health crises: Fibrosis

Kerstin Papenfuss, PhD, Director, Pharma, Deep Science Ventures, looks at the unmet need for fibrosis treatments and where drug discovery opportunities lay in terms of treatment and technology. Fibrosis is a complex pathological process characterised by excessive accumulation of extracellular matrix (ECM) components, particularly collagen, in response to chronic tissue… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Biotech #DDW Turning Science into Business Summit #Drug discovery

Register now: Learn to navigate AI-driven drug discovery

Hosted by Drug Discovery World and sponsored by The Jackson Laboratory, register now for the DDW ‘Turning Science into Business’ AI & ML summit: Navigating AI-driven drug discovery, to learn about the areas of opportunity for AI & ML in the drug discovery sector. Taking place on 30 April,… Read More

#News

AI brain
#Artificial intelligence (AI) #Drug discovery #Partnership #Precision medicine

Sonrai partners with Paige to improve AI drug discovery

AI precision medicine company Sonrai Analytics has announced a strategic partnership with AI company Paige designed to improve access to AI capabilities for precision medicine research and development. The partnership will see the integration of Paige’s foundation models with Sonrai’s cloud-based data analytics and bioinformatics platform to make… Read More

#Business & Investment #News

Human heart
#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Watch now: Streamline high-throughput cardiac screening

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

#Drug discovery

Technical Note: EtoxiClear®: Optimizing endotoxin removal

In this technical note you will learn more about: Targeted and efficient endotoxin removal: EtoxiClear® is a highly effective chromatography affinity adsorbent, specifically designed to remove low residual levels of endotoxins across a variety of biopharmaceutical processes, ensuring high product purity Scalability and cost-effectiveness: Designed for both small and large-scale… Read More

#Technical Notes

#Biotherapeutics #DNA #Drug discovery #Gut microbiome #Microbiome #Precision medicine #Synthetic biology #Synthetic DNA

Podcast: How is precision medicine making its mark in drug discovery?

This is the latest episode of the free DDW narrated podcast, titled “How is precision medicine making its mark in drug discovery?”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Accelerating biotherapy and personalised medicine with long DNA”… Read More

#News

#3D cell culture #Cell Science #Drug discovery #Organoids #Stem cells

Pushing drug discovery with stem cells, organoids and 3D cell cultures

DDW Editor Reece Armstrong looks at how advances in stem cells, organoids and 3D cell cultures are affecting drug discovery and development.  Stem cells, organoids and 3D cell cultures have emerged as promising tools that scientists can use to better understand disease and how drugs function within the human… Read More

#Exclusive Content

Machine learning concept
#AI / data analytics / healthtech / informatics #Biotech #DDW Turning Science into Business Summit #Drug discovery

Webinar: Navigating AI-driven drug discovery

Hosted by Drug Discovery World and sponsored by The Jackson Laboratory, register now for the DDW ‘Turning Science into Business’ AI & ML summit: Navigating AI-driven drug discovery, to learn about the areas of opportunity for AI & ML in the drug discovery sector. Taking place on 30 April,… Read More

#News

3D protein molecules structure
#Cell and protein analysis #Drug discovery #Nuclera #Protein chemistry / Proteomics

Nuclera expands eProtein Discovery capabilities

Nuclera has announced the addition of a new membrane protein workflow to its benchtop eProtein Discovery system.   The company says this addition will allow the expression, purification and stabilisation of challenging membrane proteins, which are often key targets in therapeutic development.   Using cell-free protein synthesis,… Read More

#News

Scientist pipetting in the lab
#Cellular assays #Drug discovery #Interview #Screening #Spinout #Turning Science into Business

Turning science into business: A step-change in adherent cell-based assays

Semarion was voted one of the SLAS2025 New Product Award winners. DDW’s Diana Spencer catches up with CEO and Co-founder Jeroen Verheyen to find out how the company has bridged the worlds of science and engineering.  DS: Congratulations on being one of the SLAS2025 New Product Award winners. Read More

#Business & Investment #Exclusive Content

#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Webinar: Advancing high-throughput cardiac screening

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening

Advancing high-throughput cardiac screening with physiologically relevant 3D iPSC-based models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in high-throughput applications… Read More

Webinar date:
Supported by Ncardia
#Webinars

AI and genomics
#AI / data analytics / healthtech / informatics #Biotech #DDW Turning Science into Business Summit #Drug discovery

Webinar: Areas of opportunity for AI and ML in drug discovery

Hosted by Drug Discovery World and sponsored by The Jackson Laboratory, register now for the DDW ‘Turning Science into Business’ AI & ML summit: Navigating AI-driven drug discovery, to learn about the areas of opportunity for AI & ML in the drug discovery sector. Taking place on 30 April,… Read More

#News